Objectives | Outcome measures | |
Primary | Test whether the virtual reality treatment leads to reduction in avoidance and distress in everyday situations. | Oxford - behavioural assessment task (O-BAT). |
Secondary | 1.Test clinical improvements by treatment type in activity levels, psychiatric symptoms, quality of life. | Activity levels: Actigraphy, time-budget measure. Psychiatric symptoms: Agoraphobia mobility inventory-avoidance, self-report O-BAT, Revised Green et al Paranoid Thoughts Scale, Paranoia Worries Questionnaire, PHQ-9, Columbia-Suicide Severity Rating Scale. Quality of life: EQ-5D-5L, ReQol, Questionnaire on the Progress of Recovery. |
2.Determine the cost-effectiveness of the virtual reality treatment. | Client Service Receipt Inventory. | |
3.Test mediation of treatment effects by changes in safety beliefs, threat cognitions, and defence (safety-seeking) behaviours. | Cognition and Defence Behaviours Questionnaire and strength of safety beliefs, vulnerability belief and threat anticipation. | |
4.Test moderation of treatment effects (negative auditory hallucinations when outside, hopelessness, appearance concerns and threat cognitions). | Hallucinations scale; Beck Hopelessness Scale; Body-Esteem Scale for Adolescents and Adults; Cognition and Defence Behaviours Questionnaire. | |
5. Assess patient satisfaction with the VR therapy. | Modified version of the Client Satisfaction Questionnaire. |
VR, virtual reality.